Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancer

This publication has 12 references indexed in Scilit:

• Early morning hydroxyproline excretion in patients with breast cancer
  Cancer, 1976
• BENIGN BREAST LESIONS AND OSTEOLYSIS
  The Lancet, 1976
• Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer
  New England Journal of Medicine, 1975
• BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASES
  The Lancet, 1975
• Hydroxyproline excretion in patients with breast cancer and response to treatment.
  BMJ, 1975
• Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell Adenocarcinoma
  New England Journal of Medicine, 1974
• The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer
  British Journal of Cancer, 1973
• Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
  Nature New Biology, 1971
• Prostaglandins: Stimulation of Bone Resorption in Tissue Culture
  Endocrinology, 1970
• A specific method for the analysis of hydroxyproline in tissues and urine
  Analytical Biochemistry, 1960